Page 17 - 《中国药房》2024年4期
P. 17

·药学研究·


          山茱萸新苷对糖尿病肾病模型小鼠的保护作用及机制
                                                                                            Δ

                                 #
                *
          王 威 ,甘啸阳,许惠琴 ,朱逸晖,束安梅,富莹雪,喻 斌,吕高虹(南京中医药大学药学院/江苏省中药药效与
          安全性评价重点实验室,南京 210023)

          中图分类号  R965      文献标志码  A      文章编号  1001-0408(2024)04-0395-06
          DOI  10.6039/j.issn.1001-0408.2024.04.03

          摘  要  目的  探讨山茱萸新苷对糖尿病肾病(DN)模型小鼠的保护作用及潜在机制。方法  将雄性KK-Ay小鼠以高脂高糖饲料
          喂养2周复制DN小鼠模型。将造模成功的小鼠随机分为模型组、氨基胍组(阳性对照,100 mg/kg)、山茱萸新苷组(100 mg/kg),另
          取雄性C57BL/6J小鼠作为正常组,每组6只。各药物组小鼠灌胃相应药液,正常组和模型组小鼠灌胃等体积生理盐水,每天1次,
          连续8周。检测各组小鼠空腹血糖(FBG)、24 h尿蛋白,血清白细胞介素12(IL-12)、IL-10、尿素氮(BUN)、肌酐(Scr)水平,观察其
          肾组织病理损伤、纤维化改变和肾小球微观结构,检测其肾皮质中晚期糖基化终末产物受体(RAGE)、Ⅳ型胶原(COL-Ⅳ)、诱导型
          一氧化氮合酶(iNOS)蛋白的表达情况。结果  与正常组比较,模型组小鼠肾皮质可见明显的炎症细胞浸润和纤维化改变,肾小球
          系膜增生严重且基底膜有大量不规则块状暗色致密物沉积;其FBG、24 h尿蛋白水平,血清IL-12、BUN、Scr水平,肾皮质RAGE、
          COL-Ⅳ、iNOS蛋白的表达量均显著升高,血清IL-10水平显著降低(P<0.01)。与模型组比较,各药物组小鼠肾脏病理损伤、纤维
          化改变及肾小球微观结构均有明显改善,上述各定量指标均普遍好转(P<0.05或P<0.01)。结论  山茱萸新苷对DN模型小鼠具
          有一定的保护作用,可抑制炎症反应,降低尿蛋白水平,缓解肾脏纤维化;上述作用可能与抑制晚期糖基终末产物/RAGE信号通
          路有关。
          关键词  山茱萸新苷;糖尿病肾病;晚期糖基化终末产物/晚期糖基化终末产物受体信号通路;炎症;肾脏纤维化

          The protective effect and mechanism of cornuside on diabetic nephropathy model mice
          WANG Wei,GAN Xiaoyang,XU Huiqin,ZHU Yihui,SHU Anmei,FU Yingxue,YU Bin,LYU Gaohong(College
          of  Pharmacy,  Nanjing  University  of  Chinese  Medicine/Jiangsu  Key  Laboratory  for  Pharmacology  and  Safety
          Evaluation of Chinese Materia Medica, Nanjing 210023, China)

          ABSTRACT   OBJECTIVE  To  investigate  the  protective  effect  and  potential  mechanism  of  cornuside  on  diabetic  nephropathy
         (DN) model mice. METHODS  Male KK-Ay mice were fed with high-fat and high-sugar diet for two weeks to reproduce the DN
          model. The successfully modeled mice were randomly grouped into model group, aminoguanidine group (positive control,100
          mg/kg)  and  cornuside  group (100  mg/kg),  and  male  C57BL/6J  mice  were  included  as  normal  group,  with  6  mice  in  each  group.
          Administration  groups  were  given  relevant  medicine  intragastrically,  and  normal  group  and  model  group  were  given  a  constant
          volume  of  normal  saline  intragastrically,  once  a  day,  for  8  consecutive  weeks.  The  levels  of  fasting  blood  glucose (FBG),  24  h
          urinary  protein,  serum  interleukin-12 (IL-12),  IL-10,  blood  urea  nitrogen (BUN)  and  serum  creatinine (Scr)  were  detected;  the
          pathological injury, fibrotic change and glomerular microstructure of renal tissue were observed; the expressions of the receptor of
          advanced glycation end products (RAGE), collagen type Ⅳ (COL-Ⅳ) and inducible nitric oxide synthase (iNOS) in renal cortex
          were  detected  in  each  group.  RESULTS  Compared  with  normal  group,  the  renal  cortex  of  mice  in  model  group  showed  obvious
          inflammatory  cell  infiltration  and  fibrotic  changes;  the  mesangial  hyperplasia  of  glomerulus  was  serious  and  the  basement
          membrane had a large number of irregular dark dense deposits; the levels of FBG and 24 h urinary protein, the serum levels of IL-
          12, BUN and Scr, and the expression levels of RAGE, COL-Ⅳ and iNOS in the renal cortex were significantly increased, while
          the  serum  level  of  IL-10  was  significantly  decreased (P<0.01).  Compared  with  the  model  group,  the  renal  pathological  injuries,
          fibrotic  changes  and  glomerular  microstructure  of  mice  in  administration  groups  were  improved  significantly,  and  the  above
          quantitative indexes were generally improved (P<0.05 or P<0.01). CONCLUSIONS Cornuside has a certain protective effect on
          DN model mice. It can inhibit the inflammatory response, reduce urinary protein excretion, and alleviate renal fibrosis, which may
                                                             be  related  to  the  inhibition  of  the  advanced  glycation  end
             Δ 基金项目 国家自然科学基金项目(No.81874359)
             *第一作者 助理实验师,硕士。研究方向:中药内分泌药理学。                   products/RAGE signaling pathway.
          E-mail:wangwei4486927@163.com                      KEYWORDS     cornuside;  diabetic  nephropathy;  advanced
             # 通信作者 教授,博士生导师,博士。研究方向:中药内分泌药理                 glycation  end  products/the  receptor  of  advanced  glycation  end
          学。E-mail:hqxu309@sina.com                          products signaling pathway; inflammation; renal fibrosis


          中国药房  2024年第35卷第4期                                                 China Pharmacy  2024 Vol. 35  No. 4    · 395 ·
   12   13   14   15   16   17   18   19   20   21   22